Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

53.69 +0.78 (+1.47%)
Streaming Delayed Price Updated: 9:54 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Cor

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the... 
Via Benzinga
Topics Death
Exposures Death
Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
From Exact Sciences Corp.
Via Business Wire
3 Stocks to Buy for the Age of Personalized Medicine
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider. 
Via InvestorPlace
A Glimpse Into The Expert Outlook On Exact Sciences Through 5 Analysts
Via Benzinga
5 Analysts Have This to Say About Exact Sciences
Via Benzinga
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
These stocks can reward patient investors. 
Via The Motley Fool
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now. 
Via InvestorPlace
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance. 
Via MarketBeat
Cathie Wood's Ark Invest Acquires Over $25.5 Million Worth Of Tesla Shares — Sells Coinbase And Robinhood Stock A Day After Bitcoin Spot ETF Approval
On Thursday, Cathie Wood-led Ark Invest made a significant move in the stock market, purchasing $25.55 million worth of shares in Tesla Inc (NASDAQ:TSLA). 
Via Benzinga
Topics ETFs
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market. 
Via InvestorPlace
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
Via Benzinga
Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday?
Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs. 
Via Benzinga
What's Going On With Exact Sciences Stock?
Exact Sciences Corporation (NASDAQ: EXAS) shares are trading higher Wednesday, and the stock has gained over 8% in the past month. Here's a look at the latest Exact Sciences news: What To Know: 
Via Benzinga
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Is This BioTech Play Severely Undervalued? BioTech Shares Promising Results From Colorectal Study
Via Benzinga
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right? 
Via The Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now. 
Via The Motley Fool
3 Stocks at the Forefront of Personalized Medicine Trend
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly 
Via InvestorPlace
A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right? 
Via The Motley Fool
The 3 Best Digital Health Stocks for Personalized Medicine
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. 
Via InvestorPlace
Cathie Wood's Ark Invest Buys $12.6M Of Zoom Shares Following Positive Earnings
Via Benzinga
3 Biotech Stocks With Big-Time Breakthrough Potential
The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave. 
Via InvestorPlace
2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030
Don't miss out on these potentially market-beating stocks. 
Via The Motley Fool
Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent
Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S. 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
3 Stocks to Love Despite All of the Wall Street Hate
We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar. 
Via InvestorPlace
7 Biotech Stocks to Buy for Big-Time Gains
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
The company makes a diagnostic tool to detect colon cancer. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.